Investors & Media

Transformative science, targeted medicines

We are working to advanceĀ a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

Annual meeting

Annual meeting

The 2019 Annual Meeting of Stockholders will be held on June 18, 2019 at 3:30 p.m. EDT at Blueprint Medicinesā€™ corporate headquarters, which are located at 45 Sidney Street, Cambridge, MA 02139.

Annual Meeting Materials
2019 Proxy Statement
2018 Annual Report